Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 77812

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
July 21, 2017
Product types
Drug
Classifications
Class I
Statuses
Terminated
Recalling firm wording
Chiavna Saffron LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY

D-1145-2017
Recall number
D-1145-2017
Initiated
July 21, 2017
Classification
Class I
Status
Terminated
Recalling firm
Chiavna Saffron LLC
Quantity
211 bottles; 339 boxes

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil

Code information

a) RO846356 Exp. 8/28/2020; b) RO246852 Exp. 8/28/2020

Distribution pattern

Nationwide